Global Pediatric Obesity Management Market Growth 2026-2032
The global Pediatric Obesity Management market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
According to public information, in 2022, there were about 1.2 billion obesity cases worldwide, among them, the number of obesity cases in China reached 230 million. Wellness & Health Research Center, the global sports economy was valued at 750 billion in 2022, 92% of global spending on physical activity occurs in Asia Pacific, North America and Europe. And China and the United States accounted for 44% of total sports spending.
LP Information, Inc. (LPI) ' newest research report, the ?Pediatric Obesity Management Industry Forecast? looks at past sales and reviews total world Pediatric Obesity Management sales in 2025, providing a comprehensive analysis by region and market sector of projected Pediatric Obesity Management sales for 2026 through 2032. With Pediatric Obesity Management sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pediatric Obesity Management industry.
This Insight Report provides a comprehensive analysis of the global Pediatric Obesity Management landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pediatric Obesity Management portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pediatric Obesity Management market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pediatric Obesity Management and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pediatric Obesity Management.
This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Obesity Management market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
According to public information, in 2022, there were about 1.2 billion obesity cases worldwide, among them, the number of obesity cases in China reached 230 million. Wellness & Health Research Center, the global sports economy was valued at 750 billion in 2022, 92% of global spending on physical activity occurs in Asia Pacific, North America and Europe. And China and the United States accounted for 44% of total sports spending.
LP Information, Inc. (LPI) ' newest research report, the ?Pediatric Obesity Management Industry Forecast? looks at past sales and reviews total world Pediatric Obesity Management sales in 2025, providing a comprehensive analysis by region and market sector of projected Pediatric Obesity Management sales for 2026 through 2032. With Pediatric Obesity Management sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pediatric Obesity Management industry.
This Insight Report provides a comprehensive analysis of the global Pediatric Obesity Management landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pediatric Obesity Management portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pediatric Obesity Management market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pediatric Obesity Management and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pediatric Obesity Management.
This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Obesity Management market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Lorcaserin
- Liraglutide
- Phentermine
- Setmelanotide
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- F.Hoffmann-La Roche
- GlaxoSmithKline
- AstraZeneca,
- Herbalife
- ApolloEndosurgery
- Ethicon, Inc.
- Takeda Pharmaceutical Company
- VIVUS
- Currax Pharmaceuticals
- What is the 10-year outlook for the global Pediatric Obesity Management market?
- What factors are driving Pediatric Obesity Management market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Pediatric Obesity Management market opportunities vary by end market size?
- How does Pediatric Obesity Management break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pediatric Obesity Management Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pediatric Obesity Management by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pediatric Obesity Management by Country/Region, 2021, 2025 & 2032
2.2 Pediatric Obesity Management Segment by Type
2.2.1 Lorcaserin
2.2.2 Liraglutide
2.2.3 Phentermine
2.2.4 Setmelanotide
2.2.5 Others
2.2.6 Pediatric Obesity Management Sales by Type
2.2.6.1 Global Pediatric Obesity Management Sales Market Share by Type (2021-2026)
2.2.6.2 Global Pediatric Obesity Management Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Pediatric Obesity Management Sale Price by Type (2021-2026)
2.3 Pediatric Obesity Management Segment by Application
2.3.1 Hospital Pharmacies
2.3.2 Retail Pharmacies
2.3.3 Online Pharmacies
2.3.4 Pediatric Obesity Management Sales by Application
2.3.4.1 Global Pediatric Obesity Management Sale Market Share by Application (2021-2026)
2.3.4.2 Global Pediatric Obesity Management Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Pediatric Obesity Management Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pediatric Obesity Management Breakdown Data by Company
3.1.1 Global Pediatric Obesity Management Annual Sales by Company (2021-2026)
3.1.2 Global Pediatric Obesity Management Sales Market Share by Company (2021-2026)
3.2 Global Pediatric Obesity Management Annual Revenue by Company (2021-2026)
3.2.1 Global Pediatric Obesity Management Revenue by Company (2021-2026)
3.2.2 Global Pediatric Obesity Management Revenue Market Share by Company (2021-2026)
3.3 Global Pediatric Obesity Management Sale Price by Company
3.4 Key Manufacturers Pediatric Obesity Management Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pediatric Obesity Management Product Location Distribution
3.4.2 Players Pediatric Obesity Management Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PEDIATRIC OBESITY MANAGEMENT BY GEOGRAPHIC REGION
4.1 World Historic Pediatric Obesity Management Market Size by Geographic Region (2021-2026)
4.1.1 Global Pediatric Obesity Management Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pediatric Obesity Management Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pediatric Obesity Management Market Size by Country/Region (2021-2026)
4.2.1 Global Pediatric Obesity Management Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pediatric Obesity Management Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pediatric Obesity Management Sales Growth
4.4 APAC Pediatric Obesity Management Sales Growth
4.5 Europe Pediatric Obesity Management Sales Growth
4.6 Middle East & Africa Pediatric Obesity Management Sales Growth
5 AMERICAS
5.1 Americas Pediatric Obesity Management Sales by Country
5.1.1 Americas Pediatric Obesity Management Sales by Country (2021-2026)
5.1.2 Americas Pediatric Obesity Management Revenue by Country (2021-2026)
5.2 Americas Pediatric Obesity Management Sales by Type (2021-2026)
5.3 Americas Pediatric Obesity Management Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pediatric Obesity Management Sales by Region
6.1.1 APAC Pediatric Obesity Management Sales by Region (2021-2026)
6.1.2 APAC Pediatric Obesity Management Revenue by Region (2021-2026)
6.2 APAC Pediatric Obesity Management Sales by Type (2021-2026)
6.3 APAC Pediatric Obesity Management Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pediatric Obesity Management by Country
7.1.1 Europe Pediatric Obesity Management Sales by Country (2021-2026)
7.1.2 Europe Pediatric Obesity Management Revenue by Country (2021-2026)
7.2 Europe Pediatric Obesity Management Sales by Type (2021-2026)
7.3 Europe Pediatric Obesity Management Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pediatric Obesity Management by Country
8.1.1 Middle East & Africa Pediatric Obesity Management Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pediatric Obesity Management Revenue by Country (2021-2026)
8.2 Middle East & Africa Pediatric Obesity Management Sales by Type (2021-2026)
8.3 Middle East & Africa Pediatric Obesity Management Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pediatric Obesity Management
10.3 Manufacturing Process Analysis of Pediatric Obesity Management
10.4 Industry Chain Structure of Pediatric Obesity Management
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pediatric Obesity Management Distributors
11.3 Pediatric Obesity Management Customer
12 WORLD FORECAST REVIEW FOR PEDIATRIC OBESITY MANAGEMENT BY GEOGRAPHIC REGION
12.1 Global Pediatric Obesity Management Market Size Forecast by Region
12.1.1 Global Pediatric Obesity Management Forecast by Region (2027-2032)
12.1.2 Global Pediatric Obesity Management Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pediatric Obesity Management Forecast by Type (2027-2032)
12.7 Global Pediatric Obesity Management Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Pediatric Obesity Management Product Portfolios and Specifications
13.1.3 Pfizer Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 F.Hoffmann-La Roche
13.2.1 F.Hoffmann-La Roche Company Information
13.2.2 F.Hoffmann-La Roche Pediatric Obesity Management Product Portfolios and Specifications
13.2.3 F.Hoffmann-La Roche Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 F.Hoffmann-La Roche Main Business Overview
13.2.5 F.Hoffmann-La Roche Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Pediatric Obesity Management Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 AstraZeneca,
13.4.1 AstraZeneca, Company Information
13.4.2 AstraZeneca, Pediatric Obesity Management Product Portfolios and Specifications
13.4.3 AstraZeneca, Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 AstraZeneca, Main Business Overview
13.4.5 AstraZeneca, Latest Developments
13.5 Herbalife
13.5.1 Herbalife Company Information
13.5.2 Herbalife Pediatric Obesity Management Product Portfolios and Specifications
13.5.3 Herbalife Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Herbalife Main Business Overview
13.5.5 Herbalife Latest Developments
13.6 ApolloEndosurgery
13.6.1 ApolloEndosurgery Company Information
13.6.2 ApolloEndosurgery Pediatric Obesity Management Product Portfolios and Specifications
13.6.3 ApolloEndosurgery Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 ApolloEndosurgery Main Business Overview
13.6.5 ApolloEndosurgery Latest Developments
13.7 Ethicon, Inc.
13.7.1 Ethicon, Inc. Company Information
13.7.2 Ethicon, Inc. Pediatric Obesity Management Product Portfolios and Specifications
13.7.3 Ethicon, Inc. Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Ethicon, Inc. Main Business Overview
13.7.5 Ethicon, Inc. Latest Developments
13.8 Takeda Pharmaceutical Company
13.8.1 Takeda Pharmaceutical Company Company Information
13.8.2 Takeda Pharmaceutical Company Pediatric Obesity Management Product Portfolios and Specifications
13.8.3 Takeda Pharmaceutical Company Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Takeda Pharmaceutical Company Main Business Overview
13.8.5 Takeda Pharmaceutical Company Latest Developments
13.9 VIVUS
13.9.1 VIVUS Company Information
13.9.2 VIVUS Pediatric Obesity Management Product Portfolios and Specifications
13.9.3 VIVUS Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 VIVUS Main Business Overview
13.9.5 VIVUS Latest Developments
13.10 Currax Pharmaceuticals
13.10.1 Currax Pharmaceuticals Company Information
13.10.2 Currax Pharmaceuticals Pediatric Obesity Management Product Portfolios and Specifications
13.10.3 Currax Pharmaceuticals Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Currax Pharmaceuticals Main Business Overview
13.10.5 Currax Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pediatric Obesity Management Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pediatric Obesity Management by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pediatric Obesity Management by Country/Region, 2021, 2025 & 2032
2.2 Pediatric Obesity Management Segment by Type
2.2.1 Lorcaserin
2.2.2 Liraglutide
2.2.3 Phentermine
2.2.4 Setmelanotide
2.2.5 Others
2.2.6 Pediatric Obesity Management Sales by Type
2.2.6.1 Global Pediatric Obesity Management Sales Market Share by Type (2021-2026)
2.2.6.2 Global Pediatric Obesity Management Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Pediatric Obesity Management Sale Price by Type (2021-2026)
2.3 Pediatric Obesity Management Segment by Application
2.3.1 Hospital Pharmacies
2.3.2 Retail Pharmacies
2.3.3 Online Pharmacies
2.3.4 Pediatric Obesity Management Sales by Application
2.3.4.1 Global Pediatric Obesity Management Sale Market Share by Application (2021-2026)
2.3.4.2 Global Pediatric Obesity Management Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Pediatric Obesity Management Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pediatric Obesity Management Breakdown Data by Company
3.1.1 Global Pediatric Obesity Management Annual Sales by Company (2021-2026)
3.1.2 Global Pediatric Obesity Management Sales Market Share by Company (2021-2026)
3.2 Global Pediatric Obesity Management Annual Revenue by Company (2021-2026)
3.2.1 Global Pediatric Obesity Management Revenue by Company (2021-2026)
3.2.2 Global Pediatric Obesity Management Revenue Market Share by Company (2021-2026)
3.3 Global Pediatric Obesity Management Sale Price by Company
3.4 Key Manufacturers Pediatric Obesity Management Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pediatric Obesity Management Product Location Distribution
3.4.2 Players Pediatric Obesity Management Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PEDIATRIC OBESITY MANAGEMENT BY GEOGRAPHIC REGION
4.1 World Historic Pediatric Obesity Management Market Size by Geographic Region (2021-2026)
4.1.1 Global Pediatric Obesity Management Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pediatric Obesity Management Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pediatric Obesity Management Market Size by Country/Region (2021-2026)
4.2.1 Global Pediatric Obesity Management Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pediatric Obesity Management Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pediatric Obesity Management Sales Growth
4.4 APAC Pediatric Obesity Management Sales Growth
4.5 Europe Pediatric Obesity Management Sales Growth
4.6 Middle East & Africa Pediatric Obesity Management Sales Growth
5 AMERICAS
5.1 Americas Pediatric Obesity Management Sales by Country
5.1.1 Americas Pediatric Obesity Management Sales by Country (2021-2026)
5.1.2 Americas Pediatric Obesity Management Revenue by Country (2021-2026)
5.2 Americas Pediatric Obesity Management Sales by Type (2021-2026)
5.3 Americas Pediatric Obesity Management Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pediatric Obesity Management Sales by Region
6.1.1 APAC Pediatric Obesity Management Sales by Region (2021-2026)
6.1.2 APAC Pediatric Obesity Management Revenue by Region (2021-2026)
6.2 APAC Pediatric Obesity Management Sales by Type (2021-2026)
6.3 APAC Pediatric Obesity Management Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pediatric Obesity Management by Country
7.1.1 Europe Pediatric Obesity Management Sales by Country (2021-2026)
7.1.2 Europe Pediatric Obesity Management Revenue by Country (2021-2026)
7.2 Europe Pediatric Obesity Management Sales by Type (2021-2026)
7.3 Europe Pediatric Obesity Management Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pediatric Obesity Management by Country
8.1.1 Middle East & Africa Pediatric Obesity Management Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pediatric Obesity Management Revenue by Country (2021-2026)
8.2 Middle East & Africa Pediatric Obesity Management Sales by Type (2021-2026)
8.3 Middle East & Africa Pediatric Obesity Management Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pediatric Obesity Management
10.3 Manufacturing Process Analysis of Pediatric Obesity Management
10.4 Industry Chain Structure of Pediatric Obesity Management
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pediatric Obesity Management Distributors
11.3 Pediatric Obesity Management Customer
12 WORLD FORECAST REVIEW FOR PEDIATRIC OBESITY MANAGEMENT BY GEOGRAPHIC REGION
12.1 Global Pediatric Obesity Management Market Size Forecast by Region
12.1.1 Global Pediatric Obesity Management Forecast by Region (2027-2032)
12.1.2 Global Pediatric Obesity Management Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pediatric Obesity Management Forecast by Type (2027-2032)
12.7 Global Pediatric Obesity Management Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Pediatric Obesity Management Product Portfolios and Specifications
13.1.3 Pfizer Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 F.Hoffmann-La Roche
13.2.1 F.Hoffmann-La Roche Company Information
13.2.2 F.Hoffmann-La Roche Pediatric Obesity Management Product Portfolios and Specifications
13.2.3 F.Hoffmann-La Roche Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 F.Hoffmann-La Roche Main Business Overview
13.2.5 F.Hoffmann-La Roche Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Pediatric Obesity Management Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 AstraZeneca,
13.4.1 AstraZeneca, Company Information
13.4.2 AstraZeneca, Pediatric Obesity Management Product Portfolios and Specifications
13.4.3 AstraZeneca, Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 AstraZeneca, Main Business Overview
13.4.5 AstraZeneca, Latest Developments
13.5 Herbalife
13.5.1 Herbalife Company Information
13.5.2 Herbalife Pediatric Obesity Management Product Portfolios and Specifications
13.5.3 Herbalife Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Herbalife Main Business Overview
13.5.5 Herbalife Latest Developments
13.6 ApolloEndosurgery
13.6.1 ApolloEndosurgery Company Information
13.6.2 ApolloEndosurgery Pediatric Obesity Management Product Portfolios and Specifications
13.6.3 ApolloEndosurgery Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 ApolloEndosurgery Main Business Overview
13.6.5 ApolloEndosurgery Latest Developments
13.7 Ethicon, Inc.
13.7.1 Ethicon, Inc. Company Information
13.7.2 Ethicon, Inc. Pediatric Obesity Management Product Portfolios and Specifications
13.7.3 Ethicon, Inc. Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Ethicon, Inc. Main Business Overview
13.7.5 Ethicon, Inc. Latest Developments
13.8 Takeda Pharmaceutical Company
13.8.1 Takeda Pharmaceutical Company Company Information
13.8.2 Takeda Pharmaceutical Company Pediatric Obesity Management Product Portfolios and Specifications
13.8.3 Takeda Pharmaceutical Company Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Takeda Pharmaceutical Company Main Business Overview
13.8.5 Takeda Pharmaceutical Company Latest Developments
13.9 VIVUS
13.9.1 VIVUS Company Information
13.9.2 VIVUS Pediatric Obesity Management Product Portfolios and Specifications
13.9.3 VIVUS Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 VIVUS Main Business Overview
13.9.5 VIVUS Latest Developments
13.10 Currax Pharmaceuticals
13.10.1 Currax Pharmaceuticals Company Information
13.10.2 Currax Pharmaceuticals Pediatric Obesity Management Product Portfolios and Specifications
13.10.3 Currax Pharmaceuticals Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Currax Pharmaceuticals Main Business Overview
13.10.5 Currax Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pediatric Obesity Management Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pediatric Obesity Management Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Lorcaserin
Table 4. Major Players of Liraglutide
Table 5. Major Players of Phentermine
Table 6. Major Players of Setmelanotide
Table 7. Major Players of Others
Table 8. Global Pediatric Obesity Management Sales by Type (2021-2026) & (K Units)
Table 9. Global Pediatric Obesity Management Sales Market Share by Type (2021-2026)
Table 10. Global Pediatric Obesity Management Revenue by Type (2021-2026) & ($ million)
Table 11. Global Pediatric Obesity Management Revenue Market Share by Type (2021-2026)
Table 12. Global Pediatric Obesity Management Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Pediatric Obesity Management Sale by Application (2021-2026) & (K Units)
Table 14. Global Pediatric Obesity Management Sale Market Share by Application (2021-2026)
Table 15. Global Pediatric Obesity Management Revenue by Application (2021-2026) & ($ million)
Table 16. Global Pediatric Obesity Management Revenue Market Share by Application (2021-2026)
Table 17. Global Pediatric Obesity Management Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Pediatric Obesity Management Sales by Company (2021-2026) & (K Units)
Table 19. Global Pediatric Obesity Management Sales Market Share by Company (2021-2026)
Table 20. Global Pediatric Obesity Management Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Pediatric Obesity Management Revenue Market Share by Company (2021-2026)
Table 22. Global Pediatric Obesity Management Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Pediatric Obesity Management Producing Area Distribution and Sales Area
Table 24. Players Pediatric Obesity Management Products Offered
Table 25. Pediatric Obesity Management Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Pediatric Obesity Management Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Pediatric Obesity Management Sales Market Share Geographic Region (2021-2026)
Table 30. Global Pediatric Obesity Management Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Pediatric Obesity Management Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Pediatric Obesity Management Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Pediatric Obesity Management Sales Market Share by Country/Region (2021-2026)
Table 34. Global Pediatric Obesity Management Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Pediatric Obesity Management Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Pediatric Obesity Management Sales by Country (2021-2026) & (K Units)
Table 37. Americas Pediatric Obesity Management Sales Market Share by Country (2021-2026)
Table 38. Americas Pediatric Obesity Management Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Pediatric Obesity Management Sales by Type (2021-2026) & (K Units)
Table 40. Americas Pediatric Obesity Management Sales by Application (2021-2026) & (K Units)
Table 41. APAC Pediatric Obesity Management Sales by Region (2021-2026) & (K Units)
Table 42. APAC Pediatric Obesity Management Sales Market Share by Region (2021-2026)
Table 43. APAC Pediatric Obesity Management Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Pediatric Obesity Management Sales by Type (2021-2026) & (K Units)
Table 45. APAC Pediatric Obesity Management Sales by Application (2021-2026) & (K Units)
Table 46. Europe Pediatric Obesity Management Sales by Country (2021-2026) & (K Units)
Table 47. Europe Pediatric Obesity Management Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Pediatric Obesity Management Sales by Type (2021-2026) & (K Units)
Table 49. Europe Pediatric Obesity Management Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Pediatric Obesity Management Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Pediatric Obesity Management Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Pediatric Obesity Management Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Pediatric Obesity Management Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Pediatric Obesity Management
Table 55. Key Market Challenges & Risks of Pediatric Obesity Management
Table 56. Key Industry Trends of Pediatric Obesity Management
Table 57. Pediatric Obesity Management Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Pediatric Obesity Management Distributors List
Table 60. Pediatric Obesity Management Customer List
Table 61. Global Pediatric Obesity Management Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Pediatric Obesity Management Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Pediatric Obesity Management Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Pediatric Obesity Management Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Pediatric Obesity Management Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Pediatric Obesity Management Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Pediatric Obesity Management Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Pediatric Obesity Management Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Pediatric Obesity Management Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Pediatric Obesity Management Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Pediatric Obesity Management Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Pediatric Obesity Management Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Pediatric Obesity Management Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Pediatric Obesity Management Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Pfizer Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 76. Pfizer Pediatric Obesity Management Product Portfolios and Specifications
Table 77. Pfizer Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. F.Hoffmann-La Roche Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 81. F.Hoffmann-La Roche Pediatric Obesity Management Product Portfolios and Specifications
Table 82. F.Hoffmann-La Roche Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. F.Hoffmann-La Roche Main Business
Table 84. F.Hoffmann-La Roche Latest Developments
Table 85. GlaxoSmithKline Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 86. GlaxoSmithKline Pediatric Obesity Management Product Portfolios and Specifications
Table 87. GlaxoSmithKline Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. GlaxoSmithKline Main Business
Table 89. GlaxoSmithKline Latest Developments
Table 90. AstraZeneca, Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 91. AstraZeneca, Pediatric Obesity Management Product Portfolios and Specifications
Table 92. AstraZeneca, Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. AstraZeneca, Main Business
Table 94. AstraZeneca, Latest Developments
Table 95. Herbalife Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 96. Herbalife Pediatric Obesity Management Product Portfolios and Specifications
Table 97. Herbalife Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Herbalife Main Business
Table 99. Herbalife Latest Developments
Table 100. ApolloEndosurgery Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 101. ApolloEndosurgery Pediatric Obesity Management Product Portfolios and Specifications
Table 102. ApolloEndosurgery Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. ApolloEndosurgery Main Business
Table 104. ApolloEndosurgery Latest Developments
Table 105. Ethicon, Inc. Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 106. Ethicon, Inc. Pediatric Obesity Management Product Portfolios and Specifications
Table 107. Ethicon, Inc. Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Ethicon, Inc. Main Business
Table 109. Ethicon, Inc. Latest Developments
Table 110. Takeda Pharmaceutical Company Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 111. Takeda Pharmaceutical Company Pediatric Obesity Management Product Portfolios and Specifications
Table 112. Takeda Pharmaceutical Company Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Takeda Pharmaceutical Company Main Business
Table 114. Takeda Pharmaceutical Company Latest Developments
Table 115. VIVUS Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 116. VIVUS Pediatric Obesity Management Product Portfolios and Specifications
Table 117. VIVUS Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. VIVUS Main Business
Table 119. VIVUS Latest Developments
Table 120. Currax Pharmaceuticals Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 121. Currax Pharmaceuticals Pediatric Obesity Management Product Portfolios and Specifications
Table 122. Currax Pharmaceuticals Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Currax Pharmaceuticals Main Business
Table 124. Currax Pharmaceuticals Latest Developments
Table 1. Pediatric Obesity Management Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pediatric Obesity Management Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Lorcaserin
Table 4. Major Players of Liraglutide
Table 5. Major Players of Phentermine
Table 6. Major Players of Setmelanotide
Table 7. Major Players of Others
Table 8. Global Pediatric Obesity Management Sales by Type (2021-2026) & (K Units)
Table 9. Global Pediatric Obesity Management Sales Market Share by Type (2021-2026)
Table 10. Global Pediatric Obesity Management Revenue by Type (2021-2026) & ($ million)
Table 11. Global Pediatric Obesity Management Revenue Market Share by Type (2021-2026)
Table 12. Global Pediatric Obesity Management Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Pediatric Obesity Management Sale by Application (2021-2026) & (K Units)
Table 14. Global Pediatric Obesity Management Sale Market Share by Application (2021-2026)
Table 15. Global Pediatric Obesity Management Revenue by Application (2021-2026) & ($ million)
Table 16. Global Pediatric Obesity Management Revenue Market Share by Application (2021-2026)
Table 17. Global Pediatric Obesity Management Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Pediatric Obesity Management Sales by Company (2021-2026) & (K Units)
Table 19. Global Pediatric Obesity Management Sales Market Share by Company (2021-2026)
Table 20. Global Pediatric Obesity Management Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Pediatric Obesity Management Revenue Market Share by Company (2021-2026)
Table 22. Global Pediatric Obesity Management Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Pediatric Obesity Management Producing Area Distribution and Sales Area
Table 24. Players Pediatric Obesity Management Products Offered
Table 25. Pediatric Obesity Management Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Pediatric Obesity Management Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Pediatric Obesity Management Sales Market Share Geographic Region (2021-2026)
Table 30. Global Pediatric Obesity Management Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Pediatric Obesity Management Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Pediatric Obesity Management Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Pediatric Obesity Management Sales Market Share by Country/Region (2021-2026)
Table 34. Global Pediatric Obesity Management Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Pediatric Obesity Management Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Pediatric Obesity Management Sales by Country (2021-2026) & (K Units)
Table 37. Americas Pediatric Obesity Management Sales Market Share by Country (2021-2026)
Table 38. Americas Pediatric Obesity Management Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Pediatric Obesity Management Sales by Type (2021-2026) & (K Units)
Table 40. Americas Pediatric Obesity Management Sales by Application (2021-2026) & (K Units)
Table 41. APAC Pediatric Obesity Management Sales by Region (2021-2026) & (K Units)
Table 42. APAC Pediatric Obesity Management Sales Market Share by Region (2021-2026)
Table 43. APAC Pediatric Obesity Management Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Pediatric Obesity Management Sales by Type (2021-2026) & (K Units)
Table 45. APAC Pediatric Obesity Management Sales by Application (2021-2026) & (K Units)
Table 46. Europe Pediatric Obesity Management Sales by Country (2021-2026) & (K Units)
Table 47. Europe Pediatric Obesity Management Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Pediatric Obesity Management Sales by Type (2021-2026) & (K Units)
Table 49. Europe Pediatric Obesity Management Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Pediatric Obesity Management Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Pediatric Obesity Management Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Pediatric Obesity Management Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Pediatric Obesity Management Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Pediatric Obesity Management
Table 55. Key Market Challenges & Risks of Pediatric Obesity Management
Table 56. Key Industry Trends of Pediatric Obesity Management
Table 57. Pediatric Obesity Management Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Pediatric Obesity Management Distributors List
Table 60. Pediatric Obesity Management Customer List
Table 61. Global Pediatric Obesity Management Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Pediatric Obesity Management Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Pediatric Obesity Management Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Pediatric Obesity Management Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Pediatric Obesity Management Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Pediatric Obesity Management Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Pediatric Obesity Management Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Pediatric Obesity Management Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Pediatric Obesity Management Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Pediatric Obesity Management Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Pediatric Obesity Management Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Pediatric Obesity Management Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Pediatric Obesity Management Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Pediatric Obesity Management Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Pfizer Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 76. Pfizer Pediatric Obesity Management Product Portfolios and Specifications
Table 77. Pfizer Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. F.Hoffmann-La Roche Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 81. F.Hoffmann-La Roche Pediatric Obesity Management Product Portfolios and Specifications
Table 82. F.Hoffmann-La Roche Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. F.Hoffmann-La Roche Main Business
Table 84. F.Hoffmann-La Roche Latest Developments
Table 85. GlaxoSmithKline Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 86. GlaxoSmithKline Pediatric Obesity Management Product Portfolios and Specifications
Table 87. GlaxoSmithKline Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. GlaxoSmithKline Main Business
Table 89. GlaxoSmithKline Latest Developments
Table 90. AstraZeneca, Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 91. AstraZeneca, Pediatric Obesity Management Product Portfolios and Specifications
Table 92. AstraZeneca, Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. AstraZeneca, Main Business
Table 94. AstraZeneca, Latest Developments
Table 95. Herbalife Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 96. Herbalife Pediatric Obesity Management Product Portfolios and Specifications
Table 97. Herbalife Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Herbalife Main Business
Table 99. Herbalife Latest Developments
Table 100. ApolloEndosurgery Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 101. ApolloEndosurgery Pediatric Obesity Management Product Portfolios and Specifications
Table 102. ApolloEndosurgery Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. ApolloEndosurgery Main Business
Table 104. ApolloEndosurgery Latest Developments
Table 105. Ethicon, Inc. Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 106. Ethicon, Inc. Pediatric Obesity Management Product Portfolios and Specifications
Table 107. Ethicon, Inc. Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Ethicon, Inc. Main Business
Table 109. Ethicon, Inc. Latest Developments
Table 110. Takeda Pharmaceutical Company Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 111. Takeda Pharmaceutical Company Pediatric Obesity Management Product Portfolios and Specifications
Table 112. Takeda Pharmaceutical Company Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Takeda Pharmaceutical Company Main Business
Table 114. Takeda Pharmaceutical Company Latest Developments
Table 115. VIVUS Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 116. VIVUS Pediatric Obesity Management Product Portfolios and Specifications
Table 117. VIVUS Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. VIVUS Main Business
Table 119. VIVUS Latest Developments
Table 120. Currax Pharmaceuticals Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 121. Currax Pharmaceuticals Pediatric Obesity Management Product Portfolios and Specifications
Table 122. Currax Pharmaceuticals Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Currax Pharmaceuticals Main Business
Table 124. Currax Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pediatric Obesity Management
Figure 2. Pediatric Obesity Management Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pediatric Obesity Management Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Pediatric Obesity Management Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pediatric Obesity Management Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pediatric Obesity Management Sales Market Share by Country/Region (2025)
Figure 10. Pediatric Obesity Management Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Lorcaserin
Figure 12. Product Picture of Liraglutide
Figure 13. Product Picture of Phentermine
Figure 14. Product Picture of Setmelanotide
Figure 15. Product Picture of Others
Figure 16. Global Pediatric Obesity Management Sales Market Share by Type in 2026
Figure 17. Global Pediatric Obesity Management Revenue Market Share by Type (2021-2026)
Figure 18. Pediatric Obesity Management Consumed in Hospital Pharmacies
Figure 19. Global Pediatric Obesity Management Market: Hospital Pharmacies (2021-2026) & (K Units)
Figure 20. Pediatric Obesity Management Consumed in Retail Pharmacies
Figure 21. Global Pediatric Obesity Management Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 22. Pediatric Obesity Management Consumed in Online Pharmacies
Figure 23. Global Pediatric Obesity Management Market: Online Pharmacies (2021-2026) & (K Units)
Figure 24. Global Pediatric Obesity Management Sale Market Share by Application (2025)
Figure 25. Global Pediatric Obesity Management Revenue Market Share by Application in 2026
Figure 26. Pediatric Obesity Management Sales by Company in 2026 (K Units)
Figure 27. Global Pediatric Obesity Management Sales Market Share by Company in 2026
Figure 28. Pediatric Obesity Management Revenue by Company in 2026 ($ millions)
Figure 29. Global Pediatric Obesity Management Revenue Market Share by Company in 2026
Figure 30. Global Pediatric Obesity Management Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Pediatric Obesity Management Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Pediatric Obesity Management Sales 2021-2026 (K Units)
Figure 33. Americas Pediatric Obesity Management Revenue 2021-2026 ($ millions)
Figure 34. APAC Pediatric Obesity Management Sales 2021-2026 (K Units)
Figure 35. APAC Pediatric Obesity Management Revenue 2021-2026 ($ millions)
Figure 36. Europe Pediatric Obesity Management Sales 2021-2026 (K Units)
Figure 37. Europe Pediatric Obesity Management Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Pediatric Obesity Management Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa Pediatric Obesity Management Revenue 2021-2026 ($ millions)
Figure 40. Americas Pediatric Obesity Management Sales Market Share by Country in 2026
Figure 41. Americas Pediatric Obesity Management Revenue Market Share by Country (2021-2026)
Figure 42. Americas Pediatric Obesity Management Sales Market Share by Type (2021-2026)
Figure 43. Americas Pediatric Obesity Management Sales Market Share by Application (2021-2026)
Figure 44. United States Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Pediatric Obesity Management Sales Market Share by Region in 2026
Figure 49. APAC Pediatric Obesity Management Revenue Market Share by Region (2021-2026)
Figure 50. APAC Pediatric Obesity Management Sales Market Share by Type (2021-2026)
Figure 51. APAC Pediatric Obesity Management Sales Market Share by Application (2021-2026)
Figure 52. China Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 56. India Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Pediatric Obesity Management Sales Market Share by Country in 2026
Figure 60. Europe Pediatric Obesity Management Revenue Market Share by Country (2021-2026)
Figure 61. Europe Pediatric Obesity Management Sales Market Share by Type (2021-2026)
Figure 62. Europe Pediatric Obesity Management Sales Market Share by Application (2021-2026)
Figure 63. Germany Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 64. France Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Pediatric Obesity Management Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Pediatric Obesity Management Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Pediatric Obesity Management Sales Market Share by Application (2021-2026)
Figure 71. Egypt Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Pediatric Obesity Management in 2026
Figure 77. Manufacturing Process Analysis of Pediatric Obesity Management
Figure 78. Industry Chain Structure of Pediatric Obesity Management
Figure 79. Channels of Distribution
Figure 80. Global Pediatric Obesity Management Sales Market Forecast by Region (2027-2032)
Figure 81. Global Pediatric Obesity Management Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Pediatric Obesity Management Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Pediatric Obesity Management Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Pediatric Obesity Management Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Pediatric Obesity Management Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Pediatric Obesity Management
Figure 2. Pediatric Obesity Management Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pediatric Obesity Management Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Pediatric Obesity Management Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pediatric Obesity Management Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pediatric Obesity Management Sales Market Share by Country/Region (2025)
Figure 10. Pediatric Obesity Management Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Lorcaserin
Figure 12. Product Picture of Liraglutide
Figure 13. Product Picture of Phentermine
Figure 14. Product Picture of Setmelanotide
Figure 15. Product Picture of Others
Figure 16. Global Pediatric Obesity Management Sales Market Share by Type in 2026
Figure 17. Global Pediatric Obesity Management Revenue Market Share by Type (2021-2026)
Figure 18. Pediatric Obesity Management Consumed in Hospital Pharmacies
Figure 19. Global Pediatric Obesity Management Market: Hospital Pharmacies (2021-2026) & (K Units)
Figure 20. Pediatric Obesity Management Consumed in Retail Pharmacies
Figure 21. Global Pediatric Obesity Management Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 22. Pediatric Obesity Management Consumed in Online Pharmacies
Figure 23. Global Pediatric Obesity Management Market: Online Pharmacies (2021-2026) & (K Units)
Figure 24. Global Pediatric Obesity Management Sale Market Share by Application (2025)
Figure 25. Global Pediatric Obesity Management Revenue Market Share by Application in 2026
Figure 26. Pediatric Obesity Management Sales by Company in 2026 (K Units)
Figure 27. Global Pediatric Obesity Management Sales Market Share by Company in 2026
Figure 28. Pediatric Obesity Management Revenue by Company in 2026 ($ millions)
Figure 29. Global Pediatric Obesity Management Revenue Market Share by Company in 2026
Figure 30. Global Pediatric Obesity Management Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Pediatric Obesity Management Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Pediatric Obesity Management Sales 2021-2026 (K Units)
Figure 33. Americas Pediatric Obesity Management Revenue 2021-2026 ($ millions)
Figure 34. APAC Pediatric Obesity Management Sales 2021-2026 (K Units)
Figure 35. APAC Pediatric Obesity Management Revenue 2021-2026 ($ millions)
Figure 36. Europe Pediatric Obesity Management Sales 2021-2026 (K Units)
Figure 37. Europe Pediatric Obesity Management Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Pediatric Obesity Management Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa Pediatric Obesity Management Revenue 2021-2026 ($ millions)
Figure 40. Americas Pediatric Obesity Management Sales Market Share by Country in 2026
Figure 41. Americas Pediatric Obesity Management Revenue Market Share by Country (2021-2026)
Figure 42. Americas Pediatric Obesity Management Sales Market Share by Type (2021-2026)
Figure 43. Americas Pediatric Obesity Management Sales Market Share by Application (2021-2026)
Figure 44. United States Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Pediatric Obesity Management Sales Market Share by Region in 2026
Figure 49. APAC Pediatric Obesity Management Revenue Market Share by Region (2021-2026)
Figure 50. APAC Pediatric Obesity Management Sales Market Share by Type (2021-2026)
Figure 51. APAC Pediatric Obesity Management Sales Market Share by Application (2021-2026)
Figure 52. China Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 56. India Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Pediatric Obesity Management Sales Market Share by Country in 2026
Figure 60. Europe Pediatric Obesity Management Revenue Market Share by Country (2021-2026)
Figure 61. Europe Pediatric Obesity Management Sales Market Share by Type (2021-2026)
Figure 62. Europe Pediatric Obesity Management Sales Market Share by Application (2021-2026)
Figure 63. Germany Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 64. France Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Pediatric Obesity Management Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Pediatric Obesity Management Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Pediatric Obesity Management Sales Market Share by Application (2021-2026)
Figure 71. Egypt Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Pediatric Obesity Management Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Pediatric Obesity Management in 2026
Figure 77. Manufacturing Process Analysis of Pediatric Obesity Management
Figure 78. Industry Chain Structure of Pediatric Obesity Management
Figure 79. Channels of Distribution
Figure 80. Global Pediatric Obesity Management Sales Market Forecast by Region (2027-2032)
Figure 81. Global Pediatric Obesity Management Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Pediatric Obesity Management Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Pediatric Obesity Management Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Pediatric Obesity Management Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Pediatric Obesity Management Revenue Market Share Forecast by Application (2027-2032)
